TipRanks
Advertisement
Advertisement

DE:LT3 Stock Latest News

AxoGen Acquires BioCircuit, Expands Peripheral Nerve Portfolio
Company AnnouncementsAxoGen Acquires BioCircuit, Expands Peripheral Nerve Portfolio
1d ago
8K
AXGN
AxoGen price target lowered to $53 from $60 at Truist
PremiumThe Fly
AxoGen price target lowered to $53 from $60 at Truist
2d ago
AXGN
AxoGen price target raised to $53 from $48 at Raymond James
PremiumThe Fly
AxoGen price target raised to $53 from $48 at Raymond James
8d ago
AXGN
AxoGen to Acquire BioCircuit, Expanding Nerve Repair Portfolio
PremiumCompany Announcements
AxoGen to Acquire BioCircuit, Expanding Nerve Repair Portfolio
23d ago
8K
AXGN
AxoGen 4.91M share Secondary priced at $42.50
PremiumThe Fly
AxoGen 4.91M share Secondary priced at $42.50
23d ago
AXGN
AxoGen to acquire BioCircuit Technologies
PremiumThe FlyAxoGen to acquire BioCircuit Technologies
23d ago
AXGN
AxoGen initiated with a Buy at Truist
Premium
The Fly
AxoGen initiated with a Buy at Truist
1M ago
AXGN
AxoGen Earnings Call Highlights Strong Growth, Margin Strain
Premium
Company Announcements
AxoGen Earnings Call Highlights Strong Growth, Margin Strain
2M ago
AXGN
AxoGen price target raised to $55 from $50 at Jefferies
PremiumThe Fly
AxoGen price target raised to $55 from $50 at Jefferies
2M ago
AXGN
AxoGen price target raised to $55 from $50 at Canaccord
PremiumThe Fly
AxoGen price target raised to $55 from $50 at Canaccord
2M ago
AXGN
AxoGen price target raised to $53 from $50 at H.C. Wainwright
PremiumThe Fly
AxoGen price target raised to $53 from $50 at H.C. Wainwright
2M ago
AXGN
AxoGen price target raised to $55 from $50 at Citizens
PremiumThe Fly
AxoGen price target raised to $55 from $50 at Citizens
2M ago
AXGN
AxoGen price target raised to $55 from $50 at Jefferies
PremiumThe FlyAxoGen price target raised to $55 from $50 at Jefferies
2M ago
AXGN
AxoGen reports Q2 adjusted EPS 12c, consensus 12c
Premium
The Fly
AxoGen reports Q2 adjusted EPS 12c, consensus 12c
2M ago
AXGN
AxoGen raises FY26 revenue view to $279M from $270M, consensus $270.92M
Premium
The Fly
AxoGen raises FY26 revenue view to $279M from $270M, consensus $270.92M
2M ago
AXGN
AxoGen boosts outlook after strong second-quarter growth
PremiumCompany Announcements
AxoGen boosts outlook after strong second-quarter growth
2M ago
8K
AXGN
Trace Biosciences announces strategic investment from Axogen
PremiumThe Fly
Trace Biosciences announces strategic investment from Axogen
2M ago
AXGN
Is AXGN a Buy, Before Earnings?
PremiumPre-Earnings
Is AXGN a Buy, Before Earnings?
2M ago
AXGN
Neuronetics appoints Nir Naor as CFO, CLO Andrew Macan to step down
PremiumThe Fly
Neuronetics appoints Nir Naor as CFO, CLO Andrew Macan to step down
2M ago
AXGN
STIM
AxoGen Shareholders Approve Directors, Auditor and Executive Pay
PremiumCompany AnnouncementsAxoGen Shareholders Approve Directors, Auditor and Executive Pay
3M ago
8K
AXGN
AxoGen price target raised to $48 from $41 at Raymond James
Premium
The Fly
AxoGen price target raised to $48 from $41 at Raymond James
5M ago
AXGN
AxoGen price target raised to $50 from $45 at Canaccord
Premium
The Fly
AxoGen price target raised to $50 from $45 at Canaccord
5M ago
AXGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >